Plasma-derived Products Market Key Highlights:
- Market Size (2024): USD 35.21 Billion
- Projected Market Size (2034): USD 73.24 Billion
- CAGR (2023-2034): 7.6%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Plasma Derived Products Market Definition
The plasma derived products market is concerned with the research, production, and commercialization of therapeutic thereby created from human blood. The growing number of chronic and autoimmune illnesses has led to an increasing global appetite for products derived from plasma. For example, immunoglobulins and clotting factors, which are included in plasma-derived products, are essential for the management of a wide array of medical conditions and are in fact in high demand and as such mostly utilized in the healthcare systems.
However, advancements in medical technology as well as increases in patient populations that require long-term care have made plasma-related medicines even more efficient. With the growth of plasma collection centers and the increase the awareness of the benefits of donating plasma, the market continues to expand. Along with the current expansion of these donation facilities around the globe, the access to plasma for the donors has improved which in turn enhances the overall availability of plasma. This system guarantees an uninterrupted and steady availability of plasma, which is essential in the making of important drugs and enhances the growth of the market.
Plasma-derived Products Market Segmentation:
By Type
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
By Application
- Hospital
- Retail Pharmacy
- Other
Plasma-derived Products Market Companies:
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
